Immunopathogenesis of Crohn's Disease
- 1 July 2005
- journal article
- review article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 29 (4S) , S118
Abstract
This review highlights the huge advances made in the understanding of Crohn's disease in the last 15 years. The pathogenic immune response in the gut wall is a highly polarised T helper cell type 1 response, probably directed against antigens of the commensal flora. There is marked over‐expression of pro‐inflammatory cytokines such as tumor necrosis factor (TNF)‐a and increased production of matrix degrading enzymes by fibroblasts and macrophages, which are probably responsible for ulceration and fistula formation. Crohn's disease runs in families and the susceptibility genes identified so far are associated with innate recognition of microbial products (Nod2) or epithelial barrier function (OCTN cation transporter genes and DLG5). Endogenous healing pathways mediated by transforming growth factor (TGF)‐β1 are inhibited because mucosal inflammatory cells express Smad7, the endogenous intracellular inhibitor of TGF‐β signalling. This makes it unlikely that enteral feeds containing TFG‐β are therapeutic by means of direct anti‐inflammatory effects, however TGF‐β may still be involved because it is a well known epithelial motogen and may promote mucosal healing, in synergy with changes in mucosal bacterial populations as a result of the change in the diet.Keywords
This publication has 53 references indexed in Scilit:
- A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut InflammationJournal of Biological Chemistry, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2Journal of Biological Chemistry, 2003
- Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB ActivationJournal of Biological Chemistry, 2002
- Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trialGut, 2002
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002
- The effect of treatment on lymphokine‐secreting cells in the intestinal mucosa of children with Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1995
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- Role of the faecal stream in the maintenance of Crohn's colitis.Gut, 1985